Increased Mortality After Radiotherapy for Pituitary Adenoma
A study has found that patients with pituitary adenomas who received radiotherapy have a significantly higher mortality rate compared to the general population. The research indicates that cerebrovascular disease is a major contributor to these excess deaths. The findings suggest a need for further analysis of radiation techniques and their effects on patient outcomes.
- ▪Patients treated with radiotherapy for pituitary adenomas had a standardized mortality ratio of 1.8.
- ▪Cerebrovascular disease was identified as the leading cause of excess mortality in these patients.
- ▪Mortality rates increased with higher doses of radiotherapy, particularly for doses above 50 Gray.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/increased-mortality-after-radiotherapy-pituitary-adenoma-2026a1000gmy?src=rss |
| Publication time | Tue, 26 May 2026 08:00:00 EDT |
| Retrieval time | 2026-05-26T12:07:48.662Z |
| Last seen | 2026-05-26T12:07:48.662Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | KalGqcakx9Dl |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
TOPLINE:Pituitary adenomas, although benign, are associated with long-term health risks including excess cerebrovascular mortality. Patients who received radiotherapy with or without undergoing surgery had a notably higher rate of all-cause mortality than the general population, with cerebrovascular disease contributing most significantly to excess deaths.METHODOLOGY:Researchers evaluated the rate of long‑term mortality in a cohort of patients with pituitary adenomas treated with radiotherapy, compared observed mortality with expected national mortality, and assessed the major contributors to excess mortality.They retrospectively reviewed data of 426 patients with pituitary adenomas (42% women) who received radiotherapy between 1962 and 1994, with follow-up extending up to 50 years; 347…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
